NCT02302625View on ClinicalTrials.gov

Cognitive Behavior Therapy for Atopic Dermatitis

NACompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions
Atopic Dermatitis
Interventions
BEHAVIORAL

Cognitive behavior therapy

Cognitive behavior therapy based on exposure and response prevention. The treatment also incorporates mindfulness training as a means to increasing tolerance for aversive thoughts and emotions associated with AD. The treatment is delivered by a licensed psychologist and comprises 10 individual weekly sessions.

Trial Locations (1)

13440

Karolinska Institutet and Gustavsberg primary care center, Stockholm

All Listed Sponsors
lead

Karolinska Institutet

OTHER

NCT02302625 - Cognitive Behavior Therapy for Atopic Dermatitis | Biotech Hunter | Biotech Hunter